000 | 01583 a2200421 4500 | ||
---|---|---|---|
005 | 20250514012250.0 | ||
264 | 0 | _c20020326 | |
008 | 200203s 0 0 eng d | ||
022 | _a0009-9201 | ||
024 | 7 |
_a10.1097/00003081-200112000-00022 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aWagner, J D | |
245 | 0 | 0 |
_aSoy phytoestrogens: research on benefits and risks. _h[electronic resource] |
260 |
_bClinical obstetrics and gynecology _cDec 2001 |
||
300 |
_a843-52 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.; Review | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aBone Density _xdrug effects |
650 | 0 | 4 |
_aBreast Neoplasms _xprevention & control |
650 | 0 | 4 |
_aCognition _xdrug effects |
650 | 0 | 4 |
_aCoronary Disease _xdrug therapy |
650 | 0 | 4 |
_aEndometrial Neoplasms _xprevention & control |
650 | 0 | 4 |
_aEstrogens, Non-Steroidal _xadverse effects |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aIsoflavones _xpharmacology |
650 | 0 | 4 |
_aOsteoporosis _xdrug therapy |
650 | 0 | 4 | _aPatient Compliance |
650 | 0 | 4 | _aPhytoestrogens |
650 | 0 | 4 | _aPlant Preparations |
650 | 0 | 4 | _aRisk Assessment |
650 | 0 | 4 |
_aSoybean Proteins _xadministration & dosage |
650 | 0 | 4 | _aTreatment Outcome |
700 | 1 | _aAnthony, M S | |
700 | 1 | _aCline, J M | |
773 | 0 |
_tClinical obstetrics and gynecology _gvol. 44 _gno. 4 _gp. 843-52 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1097/00003081-200112000-00022 _zAvailable from publisher's website |
999 |
_c11520565 _d11520565 |